bupropion has been researched along with Cardiac Failure in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To calculate incremental cost-utility ratios (cost per quality-adjusted life-year [QALY] gained) for bupropion (Zyban; GlaxoSmithKline; Gothenburg, Sweden), as compared to nicotine replacement therapy (NRT) in smoking cessation programs for a follow-up period of 20 years." | 7.73 | The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. ( Bolin, K; Lindgren, B; Willers, S, 2006) |
| "Bupropion is a new antidepressant of the aminoketone class which is structurally unrelated to the tricyclics and which is relatively free of cardiac side effects in healthy depressed patients." | 6.66 | Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. ( Bigger, JT; Giardina, EG; Glassman, AH; Johnson, LL; Roose, SP; Walsh, BT, 1987) |
| "To calculate incremental cost-utility ratios (cost per quality-adjusted life-year [QALY] gained) for bupropion (Zyban; GlaxoSmithKline; Gothenburg, Sweden), as compared to nicotine replacement therapy (NRT) in smoking cessation programs for a follow-up period of 20 years." | 3.73 | The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden. ( Bolin, K; Lindgren, B; Willers, S, 2006) |
| "Bupropion is a new antidepressant of the aminoketone class which is structurally unrelated to the tricyclics and which is relatively free of cardiac side effects in healthy depressed patients." | 2.66 | Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. ( Bigger, JT; Giardina, EG; Glassman, AH; Johnson, LL; Roose, SP; Walsh, BT, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolin, K | 1 |
| Lindgren, B | 1 |
| Willers, S | 1 |
| Roose, SP | 1 |
| Glassman, AH | 1 |
| Giardina, EG | 1 |
| Johnson, LL | 1 |
| Walsh, BT | 1 |
| Bigger, JT | 1 |
1 trial available for bupropion and Cardiac Failure
| Article | Year |
|---|---|
Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure.
Topics: Aged; Angiocardiography; Antidepressive Agents; Blood Pressure; Bupropion; Clinical Trials as Topic; | 1987 |
1 other study available for bupropion and Cardiac Failure
| Article | Year |
|---|---|
The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Topics: Adult; Aged; Bupropion; Chewing Gum; Cost-Benefit Analysis; Dopamine Uptake Inhibitors; Female; Hear | 2006 |